These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28737989)

  • 1. Incremental Effect of the Addition of Prescriber Restrictions on a State Medicaid's Pharmacy-Only Patient Review and Restriction Program.
    Keast SL; Pham T; Teel A; Nesser NJ
    J Manag Care Spec Pharm; 2017 Aug; 23(8):875-883. PubMed ID: 28737989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Abuse-Deterrent or Tamper-Resistant Opioid Formulations on Overall Health Care Expenditures in a State Medicaid Program.
    Keast SL; Owora A; Nesser N; Farmer K
    J Manag Care Spec Pharm; 2016 Apr; 22(4):347-56. PubMed ID: 27023688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns.
    Raman SR; Bush C; Karmali RN; Greenblatt LH; Roberts AW; Skinner AC
    J Manag Care Spec Pharm; 2019 Sep; 25(9):966-972. PubMed ID: 31456497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of an opioid management initiative by a state Medicaid program.
    Garcia MM; Angelini MC; Thomas T; Lenz K; Jeffrey P
    J Manag Care Spec Pharm; 2014 May; 20(5):447-54. PubMed ID: 24761816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid.
    Pham TT; Keast SL; Farmer KC; Thompson DM; Rathbun RC; Nesser NJ; Holderread BP; Skrepnek GH
    J Manag Care Spec Pharm; 2018 Jul; 24(7):664-676. PubMed ID: 29952711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the Direct Costs of Outpatient Opioid Prescriptions: A Retrospective Analysis of Data from the Rhode Island Prescription Drug Monitoring Program.
    Aroke H; Buchanan A; Wen X; Ragosta P; Koziol J; Kogut S
    J Manag Care Spec Pharm; 2018 Mar; 24(3):214-224. PubMed ID: 29485950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid Use for Pain Management After Implementation of a Medicaid Short-Acting Opioid Quantity Limit.
    Riggs CS; Billups SJ; Flores S; Patel RJ; Heilmann RM; Milchak JL
    J Manag Care Spec Pharm; 2017 Mar; 23(3):346-354. PubMed ID: 28230448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of a Federal Controlled Substance Act Schedule Change on Hydrocodone Combination Products Claims in a Medicaid Population.
    Tran S; Lavitas P; Stevens K; Greenwood BC; Clements K; Alper CJ; Lenz K; Price M; Hydery T; Arnold JL; Takeshita M; Bacon R; Peristere JP; Jeffrey PL
    J Manag Care Spec Pharm; 2017 May; 23(5):532-539. PubMed ID: 28448772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Prescriber and Pharmacy Shopping Among the Family Members of Patients Prescribed Opioids.
    Chua KP; Brummett CM; Conti RM; Haffajee RL; Prosser LA; Bohnert ASB
    JAMA Netw Open; 2019 May; 2(5):e193673. PubMed ID: 31074819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
    Leslie RS; Gilmer T; Natarajan L; Hovell M
    J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning.
    Roland CL; Ye X; Stevens V; Oderda GM
    J Manag Care Spec Pharm; 2019 Jan; 25(1):18-27. PubMed ID: 30589633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Controlled Substance Use Management on Prescribing Patterns and Health Outcomes Among High-Risk Users.
    Chen X; Ma Q; Barron J; DeVries A; Horn J; Agiro A
    J Manag Care Spec Pharm; 2019 Mar; 25(3):392-401. PubMed ID: 30816820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using prescription monitoring program data to characterize out-of-pocket payments for opioid prescriptions in a state Medicaid program.
    Hartung DM; Ahmed SM; Middleton L; Van Otterloo J; Zhang K; Keast S; Kim H; Johnston K; Deyo RA
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1053-1060. PubMed ID: 28722211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data.
    El Ibrahimi S; Hallvik S; Johnston K; Leichtling G; Choo E; Hartung DM
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1168-1174. PubMed ID: 32939909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Concurrent Opioid and Benzodiazepine Use Following a Low-Touch Prescriber Fax Intervention.
    Yang R; Carruth SE; Qiu WA; Leslie RS
    J Manag Care Spec Pharm; 2020 Feb; 26(2):160-167. PubMed ID: 32011968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Burden Associated with Outpatient Opioid Use Following Inpatient or Outpatient Surgery.
    Brummett CM; England C; Evans-Shields J; Kong AM; Lew CR; Henriques C; Zimmerman NM; Pawasauskas J; Oderda G
    J Manag Care Spec Pharm; 2019 Sep; 25(9):973-983. PubMed ID: 31313621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Florida Medicaid's State-Mandated Formulary Provision on Prescription Drug Use and Health Plan Costs in a Medicaid Managed Care Plan.
    Munshi KD; Mager D; Ward KM; Mischel B; Henderson RR
    J Manag Care Spec Pharm; 2018 Feb; 24(2):124-131. PubMed ID: 29384030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients.
    Yenikomshian MA; White AG; Carson ME; Garrison LP; Oderda GM; Biskupiak JE; Hlavacek PR; Roland CL
    J Opioid Manag; 2017; 13(5):291-301. PubMed ID: 29199395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of Prescription Opioid Deaths in the Oklahoma State Medicaid Population, 2012-2016.
    Pham TT; Skrepnek GH; Bond C; Alfieri T; Cothran TJ; Keast SL
    Med Care; 2018 Aug; 56(8):727-735. PubMed ID: 29995696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.